Literature DB >> 1624151

Chemotactic activity of Helicobacter pylori sonicate for human polymorphonuclear leucocytes and monocytes.

H Nielsen1, L P Andersen.   

Abstract

The immunopathology of Helicobacter pylori associated active chronic gastritis, which is characterised by predominance of polymorphonuclear leucocyte infiltration, is largely unknown. To evaluate the role of bacterial components as inflammatory mediators ultracentrifuged sonicated preparations were made of clinical isolates of Helicobacter pylori. The crude sonicates were shown to exhibit chemotactic activity for human polymorphonuclear leucocytes and blood monocytes in a concentration dependent fashion. The potency was comparable with previously described bacterial derived cytotaxins. The cytotaxin(s) was non-dialysable and completely destroyed by proteinase. Heat treatment did not decrease the chemotactic activity, but in sonicate subjected to 100 degrees C for 15 minutes all activity disappeared after dialysis suggesting the breakdown of a larger protein to small fragments that are still biological active. By ammonium sulphate precipitation at increasing concentrations the cytotaxin(s) was selectively found in 10% ammonium sulphate saturation, and by further molecular gel separation the chemotactic activity was found in the molecular size range from 25 to 35 kDa. The demonstration of a polymorphonuclear leucocyte and monocyte cytotaxin from Helicobacter pylori sonicate may help in understanding the mucosal immune response in gastric inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1624151      PMCID: PMC1379327          DOI: 10.1136/gut.33.6.738

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  Possible evidence of invasiveness of Helicobacter (Campylobacter) pylori.

Authors:  L P Andersen; S Holck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

Review 2.  Campylobacter pyloridis, gastritis, and peptic ulceration.

Authors:  C S Goodwin; J A Armstrong; B J Marshall
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

3.  Attempt to fulfil Koch's postulates for pyloric Campylobacter.

Authors:  B J Marshall; J A Armstrong; D B McGechie; R J Glancy
Journal:  Med J Aust       Date:  1985-04-15       Impact factor: 7.738

Review 4.  Helicobacter pylori and the pathogenesis of gastroduodenal inflammation.

Authors:  M J Blaser
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

5.  Opsonic activity of specific human IgG against Helicobacter pylori.

Authors:  M F Tosi; S J Czinn
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

6.  Local immune response to gastric Campylobacter in non-ulcer dyspepsia.

Authors:  J I Wyatt; B J Rathbone; R V Heatley
Journal:  J Clin Pathol       Date:  1986-08       Impact factor: 3.411

7.  Association of Campylobacter pylori on the gastric mucosa with antral gastritis in children.

Authors:  B Drumm; P Sherman; E Cutz; M Karmali
Journal:  N Engl J Med       Date:  1987-06-18       Impact factor: 91.245

8.  Interaction of Campylobacter pyloridis with human immune defence mechanisms.

Authors:  H Pruul; P C Lee; C S Goodwin; P J McDonald
Journal:  J Med Microbiol       Date:  1987-05       Impact factor: 2.472

9.  Staphylococcus aureus-derived chemoattractant activity for human monocytes.

Authors:  A Rot; L E Henderson; E J Leonard
Journal:  J Leukoc Biol       Date:  1986-07       Impact factor: 4.962

10.  Campylobacter pyloridis in peptic ulcer disease. I. Gastric and duodenal infection caused by C. pyloridis: histopathologic and microbiologic findings.

Authors:  L P Andersen; S Holck; C O Povlsen; L Elsborg; T Justesen
Journal:  Scand J Gastroenterol       Date:  1987-03       Impact factor: 2.423

View more
  33 in total

Review 1.  Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development.

Authors:  Y Zevering; L Jacob; T F Meyer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Effects of genotypically different strains of Helicobacter pylori on human microvascular endothelial cells in vitro.

Authors:  N Kalia; C Jones; D K Bardhan; M W Reed; J C Atherton; N J Brown
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

3.  Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model.

Authors:  N Sawai; M Kita; T Kodama; T Tanahashi; Y Yamaoka; Y Tagawa; Y Iwakura; J Imanishi
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  Ammonia as an accelerator of tumor necrosis factor alpha-induced apoptosis of gastric epithelial cells in Helicobacter pylori infection.

Authors:  M Igarashi; Y Kitada; H Yoshiyama; A Takagi; T Miwa; Y Koga
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

5.  Studies on the gastric mucosal microcirculation. 2. Helicobacter pylori water soluble extracts induce platelet aggregation in the gastric mucosal microcirculation in vivo.

Authors:  N Kalia; S Jacob; N J Brown; M W Reed; D Morton; K D Bardhan
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

6.  CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines.

Authors:  J E Crabtree; S M Farmery; I J Lindley; N Figura; P Peichl; D S Tompkins
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

7.  Expression of adhesion molecules on human granulocytes after stimulation with Helicobacter pylori membrane proteins: comparison with membrane proteins from other bacteria.

Authors:  G Enders; W Brooks; N von Jan; N Lehn; E Bayerdörffer; R Hatz
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

8.  Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype.

Authors:  J E Crabtree; A Covacci; S M Farmery; Z Xiang; D S Tompkins; S Perry; I J Lindley; R Rappuoli
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

9.  Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo.

Authors:  G R Davies; N J Simmonds; T R Stevens; M T Sheaff; N Banatvala; I F Laurenson; D R Blake; D S Rampton
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

10.  Severe gastric mucosal damage induced by NSAIDs in healthy subjects is associated with Helicobacter pylori infection and high levels of serum pepsinogens.

Authors:  L Santucci; S Fiorucci; L Patoia; F M Di Matteo; P M Brunori; A Morelli
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.